2 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow PhytoTech Therapeutics, Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms PTL201, Placebo Oral Capsule - Multiple Sclerosis | Phase 2 | Unknown | PhytoTech Therapeutics, Ltd. | 70 | 2018-03-01 | 2017-09-28 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy PLT101 - Epilepsy Intractable | Phase 2 | Completed | PhytoTech Therapeutics, Ltd. | 16 | 2017-02-13 | 2018-09-06 |
| 5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers PNL-THC:CBD soft gelatin capsule, Sativex, CBD hard capsule dose 1 - Healthy Volunteers | Phase 1 | Completed | PhytoTech Therapeutics, Ltd. | 15 | 2015-09-24 | 2017-09-20 |
Drug Resistant Epilepsy (1) · Multiple Sclerosis (1)
nabiximols (1)
Israel (3)